Medical News

RSS

Zeria obtains Japanese regulatory clearance for HemCon products

HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.

7 Feb 2011

CryoPort announces closing of first round of private placement

CryoPort, Inc. today announced it has closed the first round of a private placement with various accredited investors for $4.4 million. The Company obtained agreements to purchase 6,335,318 units at $0.70 per share; each unit consists of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $0.77 per share, pursuant to a Securities Purchase Agreement.

7 Feb 2011

State Roundup: Setting up health insurance exchanges; Community-based clinics cuts; Autism legislation; End-of-life care

The board of the Health Benefit Exchange is going to be small and mighty. ... This exchange will concentrate the health insurance buying power of millions of Californians, and will be the central force in implementing national health care reform in California (Gorn, 2/4).

7 Feb 2011

Acupuncture and exercise help women with PCOS

Acupuncture and physical exercise improve hormone levels and menstrual bleeding pattern in women with polycystic ovary syndrome (PCOS), reveals research from the University of Gothenburg, Sweden.

7 Feb 2011

Ornim receives FDA 510(k) clearance for non-invasive monitoring of blood flow in tissue

Ornim, Inc. is pleased to announce the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CerOx 3210F monitor. Additionally to its previous clearance for non-invasive monitoring of regional hemoglobin oxygen saturation in the brain or skeletal muscle, the CerOx 3210F is now also intended for use as a non-invasive monitor of blood flow in tissue of adults.

7 Feb 2011

Viewpoints: (Still) Debating health law's constitutionality; Food labels; Lawmakers' abortion divide

For state governments, the bill presents huge new costs, as we are required to enroll 15 million to 20 million more people in our Medicaid systems. ... Perhaps worse, the law expects to conscript the states as its agents in its takeover of health care. It assumes that we will set up and operate its new insurance "exchanges" for it (Indiana Gov. Mitch Daniels, 2/7).

7 Feb 2011

XDx and LabCorp enter non-hospital provider agreement for AlloMap molecular expression tests

XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests to monitor immune-mediated conditions, today announced that it has entered into a multi-year agreement with Laboratory Corporation of America Holdings to provide heart transplant patients eligible for XDx's AlloMap® test with the convenience of having their blood drawn at participating LabCorp sites across the United States.

7 Feb 2011

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

Harbor BioSciences, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today announced it is closing the clinical sites of its U.S.-based Phase I/IIa clinical trial with Apoptone® (HE3235) for castration resistant prostate cancer (CRPC) – also referred to as hormone resistant prostate cancer.

7 Feb 2011

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

Convergence Medical Devices (CMD) today announced that its co-founder, Dr. Seward Rutkove, Chief of the Division of Neuromuscular Disease at Beth Israel Deaconess Medical Center and Associate Professor of Neurology at Harvard Medical School, received Prize4Life's prestigious award for the discovery of a new biomarker for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease.

7 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others in the U.S. and Japan.

7 Feb 2011

SANUWAVE Health raises $4,102,660 from exercise of Options

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, announces that it has raised gross proceeds of $4,102,660 from the exercise of Options that were issued as part of the sale of Units to accredited investors during 2010. The Options had an expiration date of January 31, 2011.

7 Feb 2011

Unison Health Plan of Pennsylvania announces name change to UnitedHealthcare Community Plan

Unison Health Plan of Pennsylvania, based in Monroeville, has joined its Philadelphia-based sister company, AmeriChoice of Pennsylvania, under the name UnitedHealthcare Community Plan. The combined plans serve more than 280,000 health plan members in Pennsylvania.

7 Feb 2011

AstraZeneca, Targacept commence TC-5214 Phase 2b clinical trial for major depressive disorder

AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.

7 Feb 2011

Sugary snacks and lax dental hygiene put kids at risk for tooth decay

While the most prevalent focus of February is on Valentine's sweethearts, parents are well advised to also focus on the proverbial sweet tooth - particularly when it comes to their children. That's because February is National Children's Dental Health Month, an ideal time - according to Health Net, Inc. - for moms and dads to make sure that sugary snacks, as well as lax dental hygiene - aren't putting their kids at risk for tooth decay.

7 Feb 2011

UHS announces acquisition of Emergent Group and PRI Medical

Universal Hospital Services, Inc. ("UHS"), a leading provider of medical equipment management and service solutions, today announced the signing of a definitive agreement whereby UHS will acquire Emergent Group Inc. and its wholly owned subsidiary, PRI Medical Technologies, Inc., a leading provider of mobile medical lasers and surgical equipment, for $8.46 per Emergent Group share in an all-cash transaction.

7 Feb 2011

Princeton HealthCare System awards OSI Systems $2.3M patient monitoring solutions contract

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received an approximate $2.3 million contract from Princeton HealthCare System.

7 Feb 2011

Psychiatric symptoms of bed breath

A study, published in the last 2010 issue of Psychotherapy and Psychosomatics by a group of researchers of the University of Torino (Italy), has explored the personality correlates and psychiatric symptoms of bed breath.

7 Feb 2011

FTC grants Genoptix early termination of waiting period under HSR Act for Novartis' cash tender offer

Genoptix, Inc. announced today that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act") applicable to the cash tender offer by Novartis to purchase all outstanding shares of common stock of Genoptix at USD$25.00 per share.

7 Feb 2011

Emeritus enters agreement with Columbia Pacific Advisors to manage assisted living and memory care community

Emeritus Corporation, a national provider of senior living services, announced the signing of an agreement with Columbia Pacific Advisors to manage an assisted living and memory care community. This agreement represents the third such agreement entered into between the parties since August 2010 covering three communities with 269 total units.

7 Feb 2011

Bruker launches new fully automated and fast toxin identification system

Bruker today announces the North American launch of its compact, fully automated and fast toxin identification system, called pTD™ (portable Toxin Detector), at the American Society for Microbiology (ASM) Bio-Defense and Emerging Diseases Research Meeting in Washington, DC. The novel, benchtop, push-button pTD system is intended for smaller, field and mobile laboratories for use by non-expert operators in homeland security applications.

7 Feb 2011

Medical News

Zeria obtains Japanese regulatory clearance for HemCon products

CryoPort announces closing of first round of private placement

State Roundup: Setting up health insurance exchanges; Community-based clinics cuts; Autism legislation; End-of-life care

Acupuncture and exercise help women with PCOS

Ornim receives FDA 510(k) clearance for non-invasive monitoring of blood flow in tissue

Viewpoints: (Still) Debating health law's constitutionality; Food labels; Lawmakers' abortion divide

XDx and LabCorp enter non-hospital provider agreement for AlloMap molecular expression tests

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

SANUWAVE Health raises $4,102,660 from exercise of Options

Unison Health Plan of Pennsylvania announces name change to UnitedHealthcare Community Plan

AstraZeneca, Targacept commence TC-5214 Phase 2b clinical trial for major depressive disorder

Sugary snacks and lax dental hygiene put kids at risk for tooth decay

UHS announces acquisition of Emergent Group and PRI Medical

Princeton HealthCare System awards OSI Systems $2.3M patient monitoring solutions contract

Psychiatric symptoms of bed breath

FTC grants Genoptix early termination of waiting period under HSR Act for Novartis' cash tender offer

Emeritus enters agreement with Columbia Pacific Advisors to manage assisted living and memory care community

Bruker launches new fully automated and fast toxin identification system

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News